EDUCATION:
1986 - 1993 Medical School, University of Ulm, Germany
1993 - 1995 Postdoctoral Fellow in University Texas Medical Branch (UTMB), Texas, U.S.A. Laboratory of Prof. Dr. R.P. Garofalo
1994 Title of the thesis: Validity of the Amino Acid Absorption Test (AACT) for the diagnosis of chronic pancreatitis
1999 - 2001 University Texas Medical Branch (UTMB), Texas, U.S.A.
Laboratory of Dr. R.P. Garofalo
1995 - 2007 Residency program in Dept of Anesthesiology and Critical Care Medicine, University Hospital Tuebingen, Germany
since 2008 Senior Physician Intensive Care Unit Dept. of Anesthesiology and Critical Care Medicine University Hospital of Tuebingen

ADDITIONAL QUALIFICATION

• Fachkundenachweis Notfallmedizin
• Strahlenschutz: Grundkurs und Spezialkurs für Röntgendiagnostik
• Hochschuldidaktische Fortbildung: Modul Lehren und Lernen I
• Medizindidaktische Qualifikation
• Medizincontrolling
• Prüferqualifikation M2
• Zertifikation Prüfarzt
• Fortbildung im Rahmen der Württembergischen Verwaltungs- und Wirtschafts-Akademie
• OP-Management

RESEARCH ACTIVITIES

• Respiratory syncytial virus: pathogenesis and vaccines
• Viral-induced ling inflammation
• Cellular and molecular mechanisms of inflammation
• Mucosal immunology of the lung and gastrointestinal tract
• Viral infection
• Perioperative Anaphylaxis
• Inhalative anesthetics

SCIENTIFIC EXPERIENCE:

1991- 1993 Evaluation of different methods for the measurement of aminoacids in serum.

1993 - 1995 Immuneresponse to Helicobacter pylori infection, UTMB, Galveston

1999 - 2001 UTMB Galveston, CHRC, Dept. of Pediatrics, Prof. Dr. GarofaloLung inflammation during RSV infection in BALB/c mice

2001 – 2003 CMV reactivation in BALB/c mice.

GRANTS

1997-1998: DPC, Biermann; Diagnostik von Latexallergie; € 4.084,07.

1998: Fortune Projekt, Universität Tübingen, Fortüne-Antrag Nr. 234: „Nachweis von Profilin und Anti-IgE-Profilin Antikörper als Ursache
anaphylaktischer Unverträglichkeitsreaktionen in der Anaesthesie“. € 7.203,2.

1999: Fortune Projekt Universität Tübingen, Projekt-Nummer 644-0-0, „Produktion von Chemokinen im Respirationstrakt nach Infektion mit RSV und CMV“ Personalmittel: BAT IIa, für 1 Jahr.

1999: Coinvestigator: John Seally Memorial Endowement Fund for Biomediacal Research Grant, “Mechanism for RSV-inducible NF-kB mediated
pulmonary inflammation”: $ 25.000.

2003: Fortune Projekt Universität Tübingen, Projekt- Nummer 1078-1-0, „Die Rolle von MIP-1alpha während der CMV-induzierten Lungeninflammation“Personalmittel: BAT IIa, für 1 Jahr.

MEMBERSHIP IN PROFESSIONAL AND SCIENTIFIC SOCIETIES

• American Thoracic Society o Society of Mucosal Immunology
• European Society for Anesthesiologyo German Society for Anesthesiology
• German Society for Emergency Medicine
• German Society for Intensive Care Medicine
• European Society of Intensive Care Medicine

AWARDS AND HONORS:

1999 Fortune grant , University Tübingen, Germany

2001 McLaughlin Award for Excellence for Research in Infection and Immunity

2002 Young Investigator Award by the Society of Mucosal Immunology